Patents by Inventor Markus Rentsch

Markus Rentsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6407212
    Abstract: For separating non-conventional transmissible agents (NCTAs), i.e. causative agent(s), of transmissible spongiform encephalopathies (TSEs) from a solution of a protein susceptible to contamination with NCTAs, particularly from blood products, at least one adsorbent is suspended, for a time of at least 10 minutes. The absorbent is selected from kieselguhr, diatomaceous earth, silicic acid, clay minerals, metal hydroxide, metal oxihydrate, cellulose, perlite, bentonite, and water-insoluble synthetic polymers. The obtained suspension is agitated, and subsequently the adsorbent is separated from the protein solution.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: June 18, 2002
    Assignee: ZLB Bioplasma AG
    Inventors: Jean-Jacques Morgenthaler, Jacques-Andre Maring, Markus Rentsch
  • Patent number: 6136312
    Abstract: In the method for producing an immunoglobulin solution suitable for intravenous application with an IgM proportion of more than 5% by weight with respect to the immunoglobulin proportion, an IgM-containing immunoglobulin solution is treated with a protease. The intravenously well tolerated preparation obtained is characterized by not being chemically modified and by having low anticomplementary activity ACA.
    Type: Grant
    Filed: April 7, 1999
    Date of Patent: October 24, 2000
    Assignee: Rotkreuzstifung Zentrallaboratorium Blutspendedienst SRK
    Inventor: Markus Rentsch